Mereo BioPharma Group plc
MREO
$0.24
-$0.01-4.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | -- | 500.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | -- | 500.00K |
| Cost of Revenue | -- | -- | 0.00 | -- | 132.00K |
| Gross Profit | -- | -- | 0.00 | -- | 368.00K |
| SG&A Expenses | 5.22M | 4.02M | 4.20M | 6.05M | 5.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -300.00K | -- | -- |
| Total Operating Expenses | 6.91M | 8.67M | 7.62M | 9.87M | 10.25M |
| Operating Income | -6.91M | -8.67M | -7.62M | -9.87M | -9.75M |
| Income Before Tax | -7.01M | -6.72M | -7.35M | -7.02M | -14.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.01M | -6.72M | -7.35M | -7.02M | -14.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.01M | -6.72M | -7.35M | -7.02M | -14.62M |
| EBIT | -6.91M | -8.67M | -7.62M | -9.87M | -9.75M |
| EBITDA | -6.75M | -8.50M | -7.16M | -9.82M | -9.59M |
| EPS Basic | -0.22 | -0.21 | -0.23 | -0.22 | -0.46 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.06 |
| EPS Diluted | -0.22 | -0.21 | -0.23 | -0.22 | -0.46 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.03 | -0.06 |
| Average Basic Shares Outstanding | 160.71M | 160.36M | 160.08M | 159.99M | 159.89M |
| Average Diluted Shares Outstanding | 32.14M | 32.07M | 32.02M | 32.00M | 31.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |